Mark Lanasa, MD
One MedImmune Way,Gaithersburg,Maryland,United States
1
0
0
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (1)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Lizhi Niu, PhD
Fuda Cancer Hospital
Shared therapeutic areas:
Zhenlin Chen
Department of Urology, Fujian Union Hospital, Fujian Medical University
Shared therapeutic areas:
Matthew Krebs, Dr
The Christie Hospital
Shared therapeutic areas:
Francesco Montorsi, MD
IRCCS Ospedale San Raffaele
Shared therapeutic areas:
David M Latini, PhD
Baylor College of Medicine
Shared therapeutic areas:
Karim Malek, MD
Ikena Oncology
Shared therapeutic areas:
Andrea B Apolo, M.D.
National Cancer Institute (NCI)
Shared therapeutic areas:
Fei Ma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Shared therapeutic areas:
Young-kug Kim, MD, PhD
Asan Medical Center
Shared therapeutic areas:
Ahmed Elshal, MD
Mansoura University
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (1)
Showing 1 of 1 trials
A Study of Durvalumab Alone and Durvalumab+Olaparib in Advanced, Platinum-Ineligible Bladder Cancer (BAYOU)
All 1 trials loaded